Jyoti Dixit - Concepedia

Author

Jyoti Dixit

Post Graduate Institute of Medical Education and Research ORCID

Also Known As

Jyoti Dixit, Sonu Goel

Publications

273

Citations

H-Index

Concepts

All Affiliations

Post Graduate Institute of Medical Education and Research Cancer Institute (WIA)All India Institute of Medical Sciences Bhubaneswar Borooah Cancer Institute Christian Medical College, Vellore

About

Jyoti Dixit is an author at Post Graduate Institute of Medical Education and Research specializing in medicine, obstetrics, and menopause.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	26
2	Public Health	1	1	15
3	Epidemiology	1	1	15
4	Health Policy	1	1	15
5	Obstetrics	1	1	11

Jyoti Dixit

Publications

195

Citations

H-Index

Page 1

	Year	Citations
Financial toxicity of cancer treatment in India: towards closing the cancer care gap Shankar Prinja, Jyoti Dixit, Nidhi Gupta, Frontiers in Public Health	2023	73
Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database Jyoti Dixit, Nidhi Gupta, Amal Chandra Kataki, Health and Quality of Life Outcomes	2024	34
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications Shankar Prinja, Yashpaul Sharma, Jyoti Dixit, PharmacoEconomics - Open	2019	24
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol Shankar Prinja, Jyoti Dixit, Nidhi Gupta, BMJ Open	2021	23
Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis Jyoti Dixit, Shankar Prinja, Gaurav Jyani, The Lancet Global Health RheumatologyDisease ManagementPreventive MedicineHealth EconomicsClinical Effectiveness	2023	15
Access to timely cancer treatment initiation in India: extent, determinants and trends Pritam Halder, Jyoti Dixit, Nidhi Gupta, The Lancet Regional Health - Southeast Asia	2024	15
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women Nidhi Gupta, Dharna Gupta, Jyoti Dixit, Applied Health Economics and Health Policy Second-line TreatmentBreast OncologyPost-menopausal Indian WomenMedicineCancer Management	2022	11

Page 1